Medistep Healthcare Limited (NSE:MEDISTEP)

Medistep Healthcare Statistics

Total Valuation

NSE:MEDISTEP has a market cap or net worth of INR 336.77 million. The enterprise value is 330.02 million.

Market Cap	336.77M
Enterprise Value	330.02M

Important Dates

The next estimated earnings date is Tuesday, August 4, 2026.

Earnings Date	Aug 4, 2026
Ex-Dividend Date	n/a

Share Statistics

NSE:MEDISTEP has 14.21 million shares outstanding.

Current Share Class	14.21M
Shares Outstanding	14.21M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	68.96%
Owned by Institutions (%)	n/a
Float	3.74M

Valuation Ratios

The trailing PE ratio is 5.91.

PE Ratio	5.91
Forward PE	n/a
PS Ratio	0.68
PB Ratio	2.00
P/TBV Ratio	2.00
P/FCF Ratio	n/a
P/OCF Ratio	1,559.10
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	7.96
EV / Sales	0.66
EV / EBITDA	5.89
EV / EBIT	5.93
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.73, with a Debt / Equity ratio of 0.04.

Current Ratio	3.73
Quick Ratio	3.50
Debt / Equity	0.04
Debt / EBITDA	0.11
Debt / FCF	n/a
Interest Coverage	190.72

Financial Efficiency

Return on equity (ROE) is 29.06% and return on invested capital (ROIC) is 29.59%.

Return on Equity (ROE)	29.06%
Return on Assets (ROA)	18.35%
Return on Invested Capital (ROIC)	29.59%
Return on Capital Employed (ROCE)	33.04%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	2.62
Inventory Turnover	43.04

Taxes

In the past 12 months, NSE:MEDISTEP has paid 13.95 million in taxes.

Income Tax	13.95M
Effective Tax Rate	25.18%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	25.19
200-Day Moving Average	n/a
Relative Strength Index (RSI)	48.28
Average Volume (20 Days)	11,850

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:MEDISTEP had revenue of INR 496.55 million and earned 41.44 million in profits. Earnings per share was 4.01.

Revenue	496.55M
Gross Profit	60.96M
Operating Income	55.69M
Pretax Income	55.39M
Net Income	41.44M
EBITDA	56.01M
EBIT	55.69M
Earnings Per Share (EPS)	4.01

Balance Sheet

The company has 13.10 million in cash and 6.35 million in debt, with a net cash position of 6.75 million or 0.47 per share.

Cash & Cash Equivalents	13.10M
Total Debt	6.35M
Net Cash	6.75M
Net Cash Per Share	0.47
Equity (Book Value)	168.35M
Book Value Per Share	16.09
Working Capital	167.15M

Cash Flow

Operating Cash Flow	216,000
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 12.28%, with operating and profit margins of 11.22% and 8.35%.

Gross Margin	12.28%
Operating Margin	11.22%
Pretax Margin	11.15%
Profit Margin	8.35%
EBITDA Margin	11.28%
EBIT Margin	11.22%
FCF Margin	n/a

Dividends & Yields

NSE:MEDISTEP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	12.31%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NSE:MEDISTEP has an Altman Z-Score of 4.2 and a Piotroski F-Score of 3.

Altman Z-Score	4.2
Piotroski F-Score	3